JAZZ - Jazz Pharmaceuticals plc
IEX Last Trade
125.03
-0.010 -0.008%
Share volume: 20,318
Last Updated: Thu 26 Dec 2024 08:28:45 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$125.04
-0.01
-0.01%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-09 | 2023-03-01 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-02-28 | 2024-05-02 | 2024-08-01 | |
| Total revenue | 940.652 M | 972.123 M | 892.812 M | 957.317 M | 972.140 M | 1.012 B | 901.983 M | 1.024 B | |
| Cost of revenue | 133.661 M | 167.364 M | 128.644 M | 97.537 M | 102.153 M | 107.243 M | 95.487 M | 109.902 M | |
| Gross profit | 806.991 M | 804.759 M | 764.168 M | 859.780 M | 869.987 M | 904.692 M | 806.496 M | 913.923 M | |
| -0.28% | -5.04% | 12.51% | 1.19% | 3.99% | -10.85% | 13.32% | |||
| Operating expenses | 507.348 M | 555.758 M | 487.327 M | 550.082 M | 542.712 M | 612.642 M | 574.559 M | 559.257 M | |
| Selling general and admin | 358.478 M | 383.203 M | 297.917 M | 340.844 M | 308.310 M | 396.034 M | 351.712 M | 338.523 M | |
| Research and development | 148.870 M | 172.555 M | 189.410 M | 209.238 M | 234.402 M | 216.608 M | 222.847 M | 220.734 M | |
| Total expenses | 782.241 M | 860.509 M | 765.757 M | 799.681 M | 799.748 M | 871.438 M | 825.776 M | 824.382 M | |
| 10.01% | -11.01% | 4.43% | 0.01% | 8.96% | -5.24% | -0.17% | |||
| Operating income | 158.411 M | 111.614 M | 127.055 M | 157.636 M | 172.392 M | 140.497 M | 76.207 M | 199.443 M | |
| Ebit | 155.866 M | 110.841 M | 126.050 M | 155.967 M | 172.518 M | 140.036 M | 74.860 M | 199.431 M | |
| Pretax income | -62.675 M | -340.766 M | 54.096 M | 80.115 M | 99.644 M | 61.065 M | -2.949 M | 137.915 M | |
| 443.70% | -115.87% | 48.10% | 24.38% | -38.72% | -104.83% | -4,776.67% | |||
| Income tax | -43.027 M | -100.042 M | -15.324 M | -24.323 M | -47.176 M | -33.089 M | 11.669 M | -30.653 M | |
| Net income basic | -19.648 M | -240.724 M | 69.420 M | 104.438 M | 146.820 M | 94.154 M | -14.618 M | 168.568 M | |
| -1,125.18% | 128.84% | 50.44% | 40.58% | -35.87% | -115.53% | 1,253.15% | |||
| Net income | -19.648 M | -240.724 M | 69.420 M | 104.438 M | 146.820 M | 94.154 M | -14.618 M | 168.568 M | |
| -1,125.18% | 128.84% | 50.44% | 40.58% | -35.87% | -115.53% | 1,253.15% |